Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT: Ivabradine for Dysautonomia in Adolescents
NCT07881302Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of ivabradine in dysautonomia. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
dysautonomia
Beyond the preview
Go deeper on NCT07881302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07881302.